Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Paclitaxel
Drug ID BADD_D01653
Description Paclitaxel is a chemotherapeutic agent marketed under the brand name Taxol among others. Used as a treatment for various cancers, paclitaxel is a mitotic inhibitor that was first isolated in 1971 from the bark of the Pacific yew tree which contains endophytic fungi that synthesize paclitaxel. It is available as an intravenous solution for injection and the newer formulation contains albumin-bound paclitaxel marketed under the brand name Abraxane.
Indications and Usage Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer.
Marketing Status approved; vet_approved
ATC Code L01CD01
DrugBank ID DB01229
KEGG ID D00491
MeSH ID D017239
PubChem ID 36314
TTD Drug ID D0C4RB
NDC Product Code 0703-3213; 52222-0001; 65129-1308; 68083-179; 69539-159; 62422-0004; 68001-516; 68083-178; 0703-4768; 68554-0061; 46708-622; 47781-595; 62332-621; 62332-622; 63323-763; 72205-063; 60505-6230; 62332-620; 72205-062; 0517-4300; 0703-3216; 0703-3218; 17359-3055; 63126-902; 69539-158; 72205-061; 17359-4056; 49452-4961; 51446-0110; 59651-605; 0703-4764; 51446-0120; 46708-620; 61703-342; 68083-180; 0703-3217; 17359-4040; 62422-0002; 69539-157; 70860-215; 42533-111; 54893-0007; 65129-2039; 69443-022; 16714-137; 68817-134; 70860-200; 17359-4055; 65892-002; 24979-710; 46708-621
UNII P88XT4IS4D
Synonyms Paclitaxel | Anzatax | NSC-125973 | NSC 125973 | NSC125973 | Taxol | Taxol A | Bris Taxol | Taxol, Bris | Paclitaxel, (4 alpha)-Isomer | Paxene | Praxel | 7-epi-Taxol | 7 epi Taxol | Onxol
Chemical Information
Molecular Formula C47H51NO14
CAS Registry Number 33069-62-4
SMILES CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6) O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Punctate keratitis06.04.02.0030.000224%Not Available
Pyogenic granuloma24.03.06.002; 23.10.01.001; 16.26.01.001; 07.20.02.0040.000224%Not Available
Pyrexia08.05.02.0030.006290%
Radiation pneumonitis22.01.04.001; 12.05.02.002--Not Available
Rales22.12.01.0110.000224%Not Available
Rash23.03.13.001--Not Available
Rash erythematous23.03.13.0290.001500%Not Available
Rash macular23.03.13.003--Not Available
Rash maculo-papular23.03.13.0040.000806%
Rash papular23.03.13.0170.000280%Not Available
Rash vesicular23.03.13.0090.000112%Not Available
Raynaud's phenomenon24.04.03.0030.000336%Not Available
Rectal haemorrhage24.07.02.018; 07.12.03.001--
Red blood cell count decreased13.01.05.007--Not Available
Renal artery thrombosis24.01.11.001; 20.01.07.0100.000112%Not Available
Renal colic20.02.03.0100.000112%
Renal failure20.01.03.005--Not Available
Renal pain20.02.03.0030.000336%Not Available
Respiration abnormal22.02.01.0410.000302%Not Available
Respiratory arrest22.02.01.0090.001142%Not Available
Respiratory depression22.02.01.010; 17.02.05.0470.000996%Not Available
Respiratory disorder22.02.07.002--Not Available
Respiratory distress22.02.01.0120.003324%Not Available
Respiratory failure22.02.06.002; 14.01.04.0030.003134%
Retching07.01.07.0020.000560%Not Available
Retinal exudates14.07.01.007; 05.07.01.007; 24.03.07.007; 06.10.02.0030.000168%Not Available
Retinal oedema06.04.06.007; 24.03.07.0060.000112%Not Available
Retinal vascular occlusion24.04.10.004; 06.10.01.0080.000112%Not Available
Retinopathy24.03.07.003; 06.10.02.0010.000168%
Rhinitis22.07.03.006; 11.01.13.004--
The 15th Page    First    Pre   15 16 17 18 19    Next   Last    Total 27 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene